APLS APELLIS PHARMACEUTICALS INC
FollowCOM (common)
Filings received so far for Q4 2024: 2 13F filers report a position in APLS shares at 2024-12-31. The quarter is not complete: its 13F deadline is 2025-02-14, and the counts grow as filings arrive.
13D and 13G filers
No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.
Insider trades
No Form 4 transaction on this security in the data.
13F holders, Q4 2024
Filers in the available 13F reports with a share position at 2024-12-31, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.
| Holder | Shares | Value | % of portfolio | Change | Source |
|---|---|---|---|---|---|
| ALGERT GLOBAL LLC | 282,285 | $9.01M | 0.21% | +199,874 | 13F-HR/ATimeline |
| BARCLAYS PLCin group BARCLAYS PLC | 159,565 | $5.09M | <0.01% | -96,332 | 13F-HR/ATimelineGroup |